InMed Pharmaceuticals Inc. (INM): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2024-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.
$9.3K
Year ended 2024-06-30
+75.3%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-06-30 | $9.3K | -94.2% | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | $160.0K | +309.2% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | $39.1K | n/m | 2023-09-29, From 2021-07-01 |
| 2021-06-30 | $1.7K | -95.9% | 2022-09-23, From 2020-07-01 |
| 2020-06-30 | $42.6K | n/a | 2021-09-24, From 2019-07-01 |